Baseline Epigenetics as a Biomarker of Mepolizumab Response in Severe Asthma

Authors

• Hongmei Zhang, School of Public Health
• Xin Jin, School of Public Health
• Hasan Arshad, Isle of Wight NHS Trust
• Ramesh J. Kurukulaaratchy, Isle of Wight NHS Trust

Publication Title

Clinical and Experimental Allergy

Recommended Citation

Zhang, H., Jin, X., Arshad, H., & Kurukulaaratchy, R. (2026). Baseline Epigenetics as a Biomarker of Mepolizumab Response in Severe Asthma. Clinical and Experimental Allergy, 56 (3), 294-296. https://doi.org/10.1111/cea.70195